Author

Jesús Barrio Andrés

HUMAN INTESTINAL CD103+SIRP-ALPHA+ CONVENTIONAL DENDRITIC CELLS FROM PATIENTS WITH CROHN´S DISEASE PRIME IL-17+ T-CELLS
HUMAN INTESTINAL CD103+SIRP-ALPHA+ CONVENTIONAL DENDRITIC CELLS FROM PATIENTS WITH CROHN´S DISEASE PRIME IL-17+ T-CELLS

Jesús Barrio Andrés  et al.

SPORADIC VERSUS FAMILIAL PRESENTATION OF EOSINOPHILIC ESOPHAGITIS: A COMPARATIVE ANALYSIS OF THE EOE CONNECT REGISTRY ON DEMOGRAPHIC, CLINICAL CHARACTERISTICS AND EARLY-LIFE EXPOSURES
SPORADIC VERSUS FAMILIAL PRESENTATION OF EOSINOPHILIC ESOPHAGITIS: A COMPARATIVE ANALYSIS OF THE EOE CONNECT REGISTRY ON DEMOGRAPHIC, CLINICAL CHARACTERISTICS AND EARLY-LIFE EXPOSURES

Jesús Barrio Andrés  et al.

EFFICACY OF SWALLOWED TOPICAL CORTICOSTEROIDS FOR EOSINOPHILIC ESOPHAGITIS IN REAL-WORLD PRACTICE: RESULTS FROM THE EOE CONNECT REGISTRY
EFFICACY OF SWALLOWED TOPICAL CORTICOSTEROIDS FOR EOSINOPHILIC ESOPHAGITIS IN REAL-WORLD PRACTICE: RESULTS FROM THE EOE CONNECT REGISTRY

Jesús Barrio Andrés  et al.

SAFETY AND LONG-TERM PERSISTENCE OF BIOLOGICAL TREATMENTS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE. DIFFERENCES BETWEEN WOMEN AND MEN: SEXEII STUDY OF ENEIDA
SAFETY AND LONG-TERM PERSISTENCE OF BIOLOGICAL TREATMENTS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE. DIFFERENCES BETWEEN WOMEN AND MEN: SEXEII STUDY OF ENEIDA

Jesús Barrio Andrés  et al.

PHENOTYPIC DIFFERENCES IN INFLAMMATORY BOWEL DISEASE BETWEEN WOMEN AND MEN: SEXEII STUDY OF ENEIDA
PHENOTYPIC DIFFERENCES IN INFLAMMATORY BOWEL DISEASE BETWEEN WOMEN AND MEN: SEXEII STUDY OF ENEIDA

Jesús Barrio Andrés  et al.

PROTON PUMP INHIBITOR THERAPY REVERSES FIBROTIC ENDOSCOPIC FEATURES IN CHILDREN WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM THE EOE CONNECT REGISTRY
PROTON PUMP INHIBITOR THERAPY REVERSES FIBROTIC ENDOSCOPIC FEATURES IN CHILDREN WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM THE EOE CONNECT REGISTRY

Jesús Barrio Andrés  et al.

EFFICACY OF FLUTICASONE AND BUDESONIDE FORMULATIONS TO INDUCE AND MAINTAIN REMISSION OF EOSINOPHILIC ESOPHAGITIS IN REAL-WORLD PRACTICE: RESULTS FROM THE EOE CONNECT REGISTRY
EFFICACY OF FLUTICASONE AND BUDESONIDE FORMULATIONS TO INDUCE AND MAINTAIN REMISSION OF EOSINOPHILIC ESOPHAGITIS IN REAL-WORLD PRACTICE: RESULTS FROM THE EOE CONNECT REGISTRY

Jesús Barrio Andrés  et al.

COMPARISON OF THE EFFECTIVENESS OF HELICOBACTER PYLORI ERADICATION REGIMENS BETWEEN THE ELDERLY AND NON-ELDERLY POPULATIONS: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
COMPARISON OF THE EFFECTIVENESS OF HELICOBACTER PYLORI ERADICATION REGIMENS BETWEEN THE ELDERLY AND NON-ELDERLY POPULATIONS: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Jesús Barrio Andrés  et al.

DIFFERENCES OF HELICOBACTER PYLORI DIAGNOSTICS AND TREATMENTS IN THE ELDERLY AND NON-ELDERLY POPULATIONS: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
DIFFERENCES OF HELICOBACTER PYLORI DIAGNOSTICS AND TREATMENTS IN THE ELDERLY AND NON-ELDERLY POPULATIONS: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Jesús Barrio Andrés  et al.

ROLE OF COMPLIANCE IN HELICOBACTER PYLORI TREATMENTS: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
ROLE OF COMPLIANCE IN HELICOBACTER PYLORI TREATMENTS: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Jesús Barrio Andrés  et al.

ERRORS IN EMPIRICAL ANTIBIOTIC THERAPIES FOR HELICOBACTER PYLORI ERADICATION IN 45,778 PATIENTS: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
ERRORS IN EMPIRICAL ANTIBIOTIC THERAPIES FOR HELICOBACTER PYLORI ERADICATION IN 45,778 PATIENTS: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Jesús Barrio Andrés  et al.

Item 1 - 11 / 11
1